The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial

BACKGROUND: Unfractionated heparin is the most common anticoagulant used in haemodialysis (HD), although it has many potential adverse effects. Citrate dialysate (CD) has an anticoagulant effect which may allow reduction in cumulative heparin dose (CHD) compared to standard acetate dialysate (AD). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, Davina J., Leung, Kelvin, Ravani, Pietro, Quinn, Robert R., Scott-Douglas, Nairne, MacRae, Jennifer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548909/
https://www.ncbi.nlm.nih.gov/pubmed/26303208
http://dx.doi.org/10.1186/s12882-015-0144-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548909/
https://www.ncbi.nlm.nih.gov/pubmed/26303208
http://dx.doi.org/10.1186/s12882-015-0144-z

Ejemplares similares